In last trading session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT) saw 1.66 million shares changing hands with its beta currently measuring 1.50. Company’s recent per share price
In last trading session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT) saw 1.84 million shares changing hands with its beta currently measuring 1.50. Company’s recent per share price
During the recent session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT)’s traded shares were 1.22 million, with the beta value of the company hitting 1.50. At the last
In today’s recent session, 0.38 million shares of the Arcutis Biotherapeutics Inc (NASDAQ:ARQT) have been traded, and its beta is 1.51. Most recently the company’s
In the last trading session, 1.87 million Arcutis Biotherapeutics Inc (NASDAQ:ARQT) shares changed hands as the company’s beta touched 1.50. With the company’s per share
In the latest trading session, 0.44 million Arcutis Biotherapeutics Inc (NASDAQ:ARQT) shares changed hands as the company’s beta touched 1.50. With the company’s most recent
In last trading session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT) saw 1.42 million shares changing hands with its beta currently measuring 1.30. Company’s recent per share price
Arcutis Biotherapeutics Inc (NASDAQ:ARQT) has a beta value of 1.30 and has seen 1.31 million shares traded in the last trading session. The company, currently
During the recent session, Arcutis Biotherapeutics Inc (NASDAQ:ARQT)’s traded shares were 0.45 million, with the beta value of the company hitting 1.29. At the last
In the latest trading session, 0.38 million Arcutis Biotherapeutics Inc (NASDAQ:ARQT) shares changed hands as the company’s beta touched 1.31. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne
